A fine chemicalsbonanza

Pollak, Peter
October 2007
ICIS Chemical Business;10/1/2007, Vol. 272 Issue 12, p23
Trade Publication
The article presents the author's views on the changing market trends of the pharmaceuticals industry. He states that the pharmaceutical industry's fortunes have changed and more stringent patent regulatory laws and manufacturing inefficiency are proving beneficial for the fine chemical industry. He mentions that another problem faced by these industries is strict control over drug prices. He maintains that pharma companies have also lost their hold in the stock market.


Related Articles

  • Patent laws need to change. DANNEBERGER, KARL // Golfdom;Jun2014, Vol. 70 Issue 6, p38 

    The article discusses the need to revise the patent laws in Basel, Switzerland being a home to chemical and pharmaceutical companies for centuries to prevent negative impact to the government or environment. It cites the delay of bringing a product to market in the modern times compared in 1960s...

  • Chemicals firms report a dip in confidence.  // TCE: The Chemical Engineer;Jun2013, Issue 864, p10 

    The article discusses the results of a survey by the Chemicals Industry Association (CIA) which show that executives in Great Britain's chemicals and pharmaceuticals industries are less optimistic about sales and new hiring in 2013 and 2014.

  • of the pack. Ramakers, Jan // ICIS Chemical Business;10/1/2007, Vol. 272 Issue 12, p21 

    The article offers the author's views on the fine chemicals industry from the year 2001. He states that though the industry appears to become concentrated in some respects but infact it has become fragmented. He presents his views on the business of some leading companies including BASF AG,...

  • Kissing frogs, with optimism.  // In Search of the Perfect Investment;3/20/2013, p1 

    The article highlights the stock market landscape as of March 20, 2013, which in the previous days saw gruesome times but was still able to achieve an over 10% increase in 2013.

  • IP Protectors. Napoleon, Vincent J. // InsideCounsel;Jul2006, Vol. 16 Issue 176, p14 

    The article presents the author's views on intellectual property (IP) protection in the U.S. IP serves as an asset for most companies specially in the global competitive business market. There are various methods in the protection of IP in which litigation or law serves as the most-favored...

  • PROPOSED CHANGES IN THE U.S. PATENT LAWS.  // Congressional Digest;Feb62, Vol. 41 Issue 2, p39 

    Outlines proposed changes in U.S. patent laws which relate to the drug industry. Patent office description of a patent; Subject matter capable of being patented; Interferences.

  • In the Pipeline: Drug Patents in India.  // Contract Pharma;Mar/Apr2010, Vol. 12 Issue 2, p29 

    The article reviews the article "Drug Makers Decry Indian Patent Law," which appeared in the periodical "The Wall Street Journal" on February 11, 2010.

  • One World, Many Regulations. Dorris, Gregory; Rosener, James // Pharmaceutical Executive;Mar2003, Vol. 23 Issue 3, p74 

    Examines the broad legal framework that every pharmaceutical producer faces when developing, servicing, pursuing clinical evaluation, selling on manufacturing components in foreign countries. Keys to international success; General understanding of the international legal regime that governs the...

  • New patents regime to hit Indian drug industry.  // Chemical Business;Feb98, Vol. 12 Issue 2, p61 

    Focuses on the potential impact of a patent legislation on the manufacture of drugs in India. Share of patented drugs in the market; External pressures to the country's drug industry.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics